Search Results
Found 2 results
510(k) Data Aggregation
(15 days)
MODIFICATION TO AXYA MEDICAL, INC. BONE ANCHOR SYSTEM AND KIT (BAK)
Ask a specific question about this device
(64 days)
AXYA MEDICAL INC, BONE ANCHOR SYSTEM AND KIT- (BAK)
The Bone Anchor System and Kit is indicated for securing soft tissue structures to bone anchors in surgical procedures where bone anchors are indicated. Examples of these procedures include:
Shoulder procedures | (e.g. Rotator cuff repair) |
---|---|
Knee procedures | (e.g. Patellar ligament / tendon avulsion repair) |
Ankle procedures | (e.g. Achilles tendon reconstruction and repair) |
Foot procedures | (e.g. Hallux valgus reconstruction) |
Elbow procedures | (e.g. Biceps tendon reattachment) |
Bladder neck suspension | (female urinary incontinence due to urethral hypermobility) |
The BAK is indicated for use in both traditional open surgery and endoscopic surgical procedures.
The Axya Bone Anchor System consists of an electronic control module and a reusable welding activator with an integral connector cable. The Kit (BAK) consists of a disposable suture welding sleeve packaged together with appropriate and currently approved bone anchors and USP polypropylene monofilament suture. The Kit is intended for use with the reusable system components in order to complete the suture welding process for the attachment of soft tissues to bone anchors in surgical procedures where bone anchors are indicated
The Axya Bone Anchor System and Kit (BAK) is a Class II device intended to secure soft tissues to bone anchors in surgical procedures. The device uses an ultrasonic suture welding process.
Here's an analysis of the acceptance criteria and supporting study information:
1. Acceptance Criteria and Reported Device Performance
The provided document does not explicitly state specific numerical acceptance criteria for the device's performance. Instead, it focuses on demonstrating that the BAK is substantially equivalent to predicate devices and that its performance (specifically suture strength and safety) meets established standards and is comparable to traditional methods.
The reported device performance is presented as:
Acceptance Criteria (Inferred from study objectives) | Reported Device Performance |
---|---|
Suture Knot Strength: Ensure sutures placed by the welding process exhibit strength comparable to or exceeding USP requirements for respective sizes and types of suture materials. | - "Knot strength" characteristics substantially above the USP requirements for the respective sizes and types of suture materials tested. - USP size 2 polypropylene monofilament sutures secured by a weld formed with the AxyaWeld Tips exceed the USP knot strength requirements. - Strength requirements are met regardless of the angle of applied tension between the suture and the bone anchor stem. |
Suture Fatigue and Elongation: Demonstrate acceptable long-term performance under cyclic loading. | - Evaluated in bench-test models. - Welded sutures found to meet suggested criteria following cyclic testing. |
Safety - Histopathologic Change: Confirm no significant difference in safety or efficacy compared to traditional suture placement, specifically regarding tissue reactions to the weld. | - No histopathologic change seen at the suture implant sites where the suture was sealed with ultrasonic energy in both dorsal skin and bowel tissue of New Zealand rabbits. - Conclusion: No significant difference in safety or efficacy between traditional manual knot-tying and suture welding. |
Safety - Thermal Injury: Ensure no risk of thermal injury to the patient from the ultrasonic energy source. | - No portion of the ultrasonic generator comes into contact with human tissues due to design features. - Virtually no risk of causing a thermal injury to the patient. |
Sterility: Achieve a specified sterility assurance level (SAL). | - Sterilized by exposure to gamma irradiation at 2.5 Mrads, providing a SAL of at least 10^-6. - Alternatively, by ethylene oxide gas sterilization, also providing a SAL of 10^-6. - Sterility processes, manufacturing process, and packaging process are validated by the manufacturer. |
Biocompatibility: Fabricated from materials with a substantial history of use in medical devices. | - Materials from which the Axya device is fabricated have an established history of use in medical applications. - Specific materials used by Axya have been thoroughly tested in accordance with applicable FDA guidelines. |
2. Sample Size Used for the Test Set and Data Provenance
The document describes two main types of studies:
-
In Vitro (Bench-test) Studies:
- Sample Size: Not explicitly stated with specific numbers for each test (e.g., number of sutures tested for knot strength, number of samples for fatigue). It generally refers to "data presented" and "tests" covering "respective sizes and types of suture materials" and "USP size 2 polypropylene monofilament sutures."
- Data Provenance: Conducted "in vitro" and described as "bench-test models." No country of origin is specified, but it's implied to be part of the manufacturer's testing in the US. The data is retrospective in the sense that it refers back to studies conducted for prior 510(k) clearances (ASLS and SWK).
-
Animal Studies:
- Sample Size: Not explicitly stated as a number of animals or implant sites. It mentions "New Zealand rabbits" for dorsal skin and bowel tissue studies. Without specific numbers, it's impossible to quantify the sample size.
- Data Provenance: Animal models (New Zealand rabbits). The studies were previously conducted and referenced from a prior 510(k) (K980988), making them retrospective in the context of this current submission.
3. Number of Experts Used to Establish the Ground Truth for the Test Set and Their Qualifications
This information is not provided in the document.
- For the in vitro studies, "ground truth" would be objective measurements (e.g., force required for failure, cycle count to failure), not expert consensus.
- For the animal studies, the "investigators" concluded on safety and efficacy based on histopathology. However, the number of investigators/pathologists, their specific qualifications, or how their consensus was reached is not mentioned.
4. Adjudication Method
This information is not provided in the document. Given the nature of the studies (in vitro measurements and animal histopathology from earlier submissions), a formal human-reader adjudication method as often seen in imaging studies (e.g., 2+1) is unlikely to apply directly. The "investigators" formed conclusions, but the method of their consensus/adjudication is not detailed.
5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study Was Done
No, an MRMC comparative effectiveness study was not done.
This type of study is primarily relevant for diagnostic imaging devices where human readers interpret medical images with and without AI assistance to assess changes in diagnostic accuracy or efficiency. The Axya Bone Anchor System is a surgical tool, not a diagnostic imaging device. The comparative effectiveness assessment focused on mechanical properties (suture strength) and biological safety (tissue reaction) compared to traditional methods, not human reader performance.
6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) Was Done
Yes, in essence, standalone performance was evaluated for the device's core function.
The in vitro studies on suture strength, fatigue, and elongation represent the standalone mechanical performance of the welded suture. The animal safety studies evaluated the biological response to the device's output (welded suture) without direct human intervention impacting the "welding" function itself during the test. The "algorithm" here isn't a software algorithm but rather the mechanical and ultrasonic welding process. The efficacy of this process was demonstrated independently of varied human surgical technique (e.g., how a human would tie a knot).
7. The Type of Ground Truth Used
- Quantitative Bench-Test Data: For suture strength and fatigue, the ground truth was derived from objective, measurable outcomes obtained from bench-tests (e.g., force measurements for knot strength, cycle counts for fatigue). These are "physical performance metrics."
- Histopathology: For the animal safety studies, the ground truth for tissue reaction and safety was established by detailed microscopic examination of tissue samples (histopathology) at the implant sites. This is a "pathology" based ground truth.
8. The Sample Size for the Training Set
Not applicable.
The Axya Bone Anchor System is a mechanical device, not a machine learning or AI-driven system that requires a "training set" in the conventional sense. The device's function is deterministic based on its design and physical principles. Its development would involve engineering design, prototyping, and testing, not statistical training on a dataset.
9. How the Ground Truth for the Training Set Was Established
Not applicable.
As there is no training set as understood in AI/ML, there is no ground truth established for a training set. The device's performance is demonstrated through its inherent mechanical and biological properties, not learned patterns from data.
Ask a specific question about this device
Page 1 of 1